Canine separation anxiety (SA) is treated with a combination of behavior modification and pharmacological intervention, with both components initiated simultaneously at the earliest sign of clinical distress. SA should be considered a behavioral emergency, and delaying treatment worsens prognosis as further sensitization makes the condition harder to resolve.AAHA Clinical G…+1

Behavioral modification is the cornerstone of treatment and centers on systematic desensitization and counterconditioning to being left alone. Exercises should habituate the dog to solitude while reducing owner dependence.Animal Welfare+1 Dogs with SA should be left alone as rarely as possible during the treatment period; day care or dog sitters are recommended for owners who cannot bring their dogs to work.MSD Vet Manuals Where access to an animal behavior specialist is not possible, owner-directed advice should be limited to five or fewer clear instructions to maximize adherence.Veterinary Medi…

Departure cue management requires careful consideration. Increasing the predictability of the owner's departure — rather than using false departure cues — is recommended, as unpredictable departures are more stressful given the dog's existing anxiety state.Animal Welfare When practicing graduated departure exercises, these should be performed in a location different from where the dog is actually left alone, to prevent contextual fear conditioning to the home environment.Animal Welfare Video monitoring is recommended annually to detect less obvious signs of distress that owners may not recognize.AAHA Clinical G…

Structured interaction programs that provide consistent, predictable owner responses decrease anxiety and build self-control, improving the dog's ability to manage arousal and learn new responses to departure stimuli.MSD Vet Manuals Punishment-based techniques are contraindicated, as they increase fear and stress.Journal of the…

First-line pharmacological treatment is clomipramine or fluoxetine, both FDA-approved for canine SA in the United States. Controlled studies have demonstrated efficacy for both drugs in combination with behavior modification.AAHA Clinical G…+1 Clomipramine hydrochloride is dosed at 2–4 mg/kg PO q12h (4–8 mg/kg/day total); a typical starting point within this range is 2.2 mg/kg PO q12h.Journal of the… Fluoxetine is dosed at 0.7 mg/kg PO q24h based on reported clinical use.Journal of the… Both drugs require 4–6 weeks to reach full effect.Journal of the…+1

A short-acting anxiolytic should be added during the onset period while waiting for the daily medication to reach therapeutic effect. Clorazepate dipotassium is dosed at 0.5–2.0 mg/kg PO, administered 30–60 minutes prior to the owner's departure.Journal of the… Alprazolam has a shorter duration of action and owner satisfaction with it is lower when duration of effect is the primary concern.Journal of the… Adverse reactions to paroxetine and lorazepam have been documented in individual patients, and patient-specific drug tolerance should be assessed.Canadian Veteri…

Trazodone is widely used in clinical practice as a short-acting adjunctive anxiolytic, though it is not FDA-approved for canine behavioral indications.Journal of the… Gabapentin at 14.3 mg/kg PO q12h has been used as an adjunctive agent for anxiety disorders in dogs, with potential side effects including sedation, ataxia, lethargy, and vomiting.Journal of the…

Medications have a higher likelihood of treatment success when initiated early in the development of observed anxiety, and duration of treatment depends on severity and response.AAHA Clinical G…

Would you like guidance on how to structure the graduated departure desensitization protocol for owners to implement at home?